Alper Yazıcı

Alper Yazıcı

Auto-generated profile, based on publicly available information

Alper Yazıcı

Department of Ophthalmology, Batı Göz Hospital, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
AYAlper Yazici
Alper Yazici
POPinar Ozdal
Pinar Ozdal
ITIbrahim Taskintuna
Ibrahim Taskintuna
SKSevim Kavuncu
Sevim Kavuncu
GKGultekin Koklu
Gultekin Koklu
Purpose: To evaluate the efficacy and safety of trimethoprim/sulfamethoxazole and azithromycin combination for the treatment of ocular toxoplasmosis. Methods: Nineteen ocular toxoplasmosis patients treated with trimethoprim/sulfamethoxazole and azithromycin ± corticosteroid combination were retrospectively reviewed. Demographic data, clinical findings, the time interval until resolution of inflammation, recurrences, and drug side effects were collected. Results: The mean follow-up time of the patients was 25.0 ± 22.5 (range; 6 –66) months. Final visual acuity improved with a mean of 6 ± 4 lines in 15 patients (78.9%). Inflammatory findings began to subside within 14.8 ± 10.0 days. Three patients (15.8%) had recurrent attack. Only 1 patient (5.3%) had side effects from therapy. Conclusions: Trimethoprim/sulfamethoxazole and azithromycin combination is an effective and safe treatment modality for the treatment of ocular toxoplasmosis.

1 February 2018 in Journal of Ocular Pharmacology and Therapeutics
Verified
Journal Article
Closed access
AYAlper Yazıcı
Alper Yazıcı
ESEsin Sarı
Esin Sarı
EAErkan Ayhan
Erkan Ayhan
GŞGözde Şahin
Gözde Şahin
NTNesime Setge Tıskaoğlu
Nesime Setge Tıskaoğlu
SESıtkı Samet Ermiş
Sıtkı Samet Ermiş
Purpose: To evaluate the effects of acetylsalicylic acid (aspirin) on tear film parameters and dry eye disease. Methods: Fifty-seven patients using low-dose aspirin regularly for antiaggregant purposes as well as 49 controls, who required antiaggregant treatment but who had not yet started, were included in the study. Tear osmolarity, tear break-up time (TBUT), Schirmer and Oxford grading of ocular surface staining were performed on all patients and dry eye symptomatology was assessed using the ocular surface disease index questionnaire (OSDI). Results: The mean osmolarity was 302.11 ± 16.22 mOsm/L in the aspirin group and 313.88 ± 19.57 mOsm/L in the control group ( P < 0.01). The mean Schirmer's score was 24.16 ± 10.52 mm and 21.94 ± 10.11 mm ( P = 0.232), TBUT was 13.61 ± 3.31 s and 10.39 ± 4.46 s ( P < 0.01), OSDI score was 5.15 ± 5.98 and 16.94 ± 14.17 ( P < 0.01), and Oxford score was 0.12 ± 0.33 and 0.12 ± 0.44 in aspirin and control groups, respectively ( P = 0.99). Dry eye diagnosis was lower in the aspirin group, but statistical significance was present only in TBUT and osmolarity-based dry eye diagnosis ( P ≤ 0.01). In terms of symptom-based dry eye diagnosis with the threshold of OSDI ≥23, none of the aspirin group had dry eye diagnosis, whereas 32.6% of the control group had the diagnosis ( P < 0.01). Conclusions: The use of low-dose aspirin might be great option for treatment of ocular surface inflammatory disease through increasing TBUT and decreasing tear osmolarity with a resultant symptomatic satisfaction.

7 September 2022 in Orbit
Verified
Journal Article
Closed access
NTNesime Setge Tıskaoğlu
Nesime Setge Tıskaoğlu
AYAlper Yazıcı
Alper Yazıcı
To determine the effect of unilateral primary acquired nasolacrimal obstruction (PANDO) on ocular surface parameters in PANDOeyes and fellow eyes and changes in these parameters after dacryocystorh...

1 December 2017 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
EBErdoğan Bülbül
Erdoğan Bülbül
AYAlper Yazıcı
Alper Yazıcı
BYBahar Yanik
Bahar Yanik
GDGülen Demirpolat
Gülen Demirpolat
Aim: Trochlear apparatus calcification (TAC) can be an incidental finding in multidetector computed tomography (MDCT) scans. TAC may be misdiagnosed as a foreign body especially in trauma patients. In this study we aim to determine the incidence and types of TAC with cranial and paranasal MDCT scans.Materials and Methods: Consecutive 452 MDCT scans were evaluated retrospectively. Repeated exams and patients with orbital wall fracture history were excluded. CT scans were obtained by a 64-slice scanner with 0.5 mm slice thickness. Reformatted and three-dimension volume rendered images in bone window were used to assess the calcification presence and type.Results: Four hundred forty-one MDCT exams included to study. TACs detected in 31 (7.5%) subjects. TAC was unilateral in 24 (77.4%) and bilateral in seven (22.6%) subjects. There was no significant correlation with aging (p=0.681) and between genders (p=0.808). “Dot-like” TAC was the most common type (n=12, 31.6%). The other types were “inverted-U” (n=11, 28.9%), “linear” (n=8, 21%), “comma” (n=6, 15.6%), respectively. Eight (21%) of TACs were attaching the orbital wall, mostly in “comma” type.Conclusion: The TAC incidence in our study was compatible with literature. Four different types of TAC, including, “dot-like”, “inverted U”, “linear” and “comma” types detected. TACs were usually discrete from the orbital wall however they were occasionally attached. “Linear” type TAC and attachment to orbital wall described for the first time in this study. Knowledge of the TAC appearance may be helpful to differentiate TACs from foreign bodies.

15 July 2015 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
AKAdil Kılıç
Adil Kılıç
SESıtkı Samet Ermiş
Sıtkı Samet Ermiş
ESEsin Sarı
Esin Sarı
AYAlper Yazıcı
Alper Yazıcı

5 October 2024 in Güncel Retina Dergisi (Current Retina Journal)
Verified
Journal Article
Open access
PDF file
NTNesime Setge Ti̇sKaoğlu
Nesime Setge Ti̇sKaoğlu
AYAlper Yazici
Alper Yazici
Damage to the optic nerve and its functioning is referred to as optic neuropathy, unlike the peripheral nervous system (PNS), the optic nerve is part of the central nervous system (CNS), which presents limitations in its regenerative abilities. Both intrinsic and extrinsic factors contribute to these limitations. Strategies for neuroprotection and neuroregeneration have been studied and implemented to address these challenges. While there is no definite treatment in the past two decades there have been many advances in the modulation of inflammation, apoptosis, neurotrophic factors and stem cell replacement strategies. The advances in these areas could transform our approach to optic nerve impairment in the future.